144 related articles for article (PubMed ID: 18155739)
1. Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs. Part III.
Rao PN; Cessac JW; Boyd JW; Hanson AD; Shah J
Steroids; 2008 Feb; 73(2):171-83. PubMed ID: 18155739
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs--Part II.
Rao PN; Cessac JW; Boyd JW; Hanson AD; Shah J
Steroids; 2008 Feb; 73(2):158-70. PubMed ID: 18155740
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs.
Rao PN; Cessac JW; Tinley TL; Mooberry SL
Steroids; 2002 Dec; 67(13-14):1079-89. PubMed ID: 12441194
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 2- and 17-substituted estrone analogs and their antiproliferative structure-activity relationships compared to 2-methoxyestradiol.
Shah JH; Agoston GE; Suwandi L; Hunsucker K; Pribluda V; Zhan XH; Swartz GM; LaVallee TM; Treston AM
Bioorg Med Chem; 2009 Oct; 17(20):7344-52. PubMed ID: 19762246
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activities of 3-modified 2-methoxyestradiol analogs.
Suwandi LS; Agoston GE; Shah JH; Hanson AD; Zhan XH; Lavallee TM; Treston AM
Bioorg Med Chem Lett; 2009 Nov; 19(22):6459-62. PubMed ID: 19782568
[TBL] [Abstract][Full Text] [Related]
6. Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines.
Ouyang X; Piatnitski EL; Pattaropong V; Chen X; He HY; Kiselyov AS; Velankar A; Kawakami J; Labelle M; Smith L; Lohman J; Lee SP; Malikzay A; Fleming J; Gerlak J; Wang Y; Rosler RL; Zhou K; Mitelman S; Camara M; Surguladze D; Doody JF; Tuma MC
Bioorg Med Chem Lett; 2006 Mar; 16(5):1191-6. PubMed ID: 16377187
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel diaryl ethers and their evaluation as antimitotic agents.
In JK; Lee MS; Yang JE; Kwak JH; Lee H; Boovanahalli SK; Lee K; Kim SJ; Moon SK; Lee S; Choi NS; Ahn SK; Jung JK
Bioorg Med Chem Lett; 2007 Mar; 17(6):1799-802. PubMed ID: 17276056
[TBL] [Abstract][Full Text] [Related]
8. Concise syntheses of N-aryl-5,6,7-trimethoxyindoles as antimitotic and vascular disrupting agents: application of the copper-mediated Ullmann-type arylation.
Lee HY; Chang JY; Chang LY; Lai WY; Lai MJ; Shih KH; Kuo CC; Chang CY; Liou JP
Org Biomol Chem; 2011 May; 9(9):3154-7. PubMed ID: 21416070
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiproliferative evaluation of certain 4-anilino-8-methoxy-2-phenylquinoline and 4-anilino-8-hydroxy-2-phenylquinoline derivatives.
Chen YL; Huang CJ; Huang ZY; Tseng CH; Chang FS; Yang SH; Lin SR; Tzeng CC
Bioorg Med Chem; 2006 May; 14(9):3098-105. PubMed ID: 16412647
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antiproliferative, and pharmacokinetic properties of 3- and 17-double-modified analogs of 2-methoxyestradiol.
Agoston GE; Shah JH; Suwandi L; Hanson AD; Zhan X; LaVallee TM; Pribluda V; Treston AM
Bioorg Med Chem Lett; 2009 Nov; 19(21):6241-4. PubMed ID: 19782564
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of 16-modified analogs of 2-methoxyestradiol.
Agoston GE; Shah JH; Lavallee TM; Zhan X; Pribluda VS; Treston AM
Bioorg Med Chem; 2007 Dec; 15(24):7524-37. PubMed ID: 17910916
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of 1-benzyl-4,5,6-trimethoxyindoles as a novel class of potent antimitotic agents.
Lai MJ; Kuo CC; Yeh TK; Hsieh HP; Chen LT; Pan WY; Hsu KY; Chang JY; Liou JP
ChemMedChem; 2009 Apr; 4(4):588-93. PubMed ID: 19266513
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate.
Jourdan F; Leese MP; Dohle W; Hamel E; Ferrandis E; Newman SP; Purohit A; Reed MJ; Potter BV
J Med Chem; 2010 Apr; 53(7):2942-51. PubMed ID: 20225862
[TBL] [Abstract][Full Text] [Related]
14. Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones.
Chang CY; Chuang HY; Lee HY; Yeh TK; Kuo CC; Chang CY; Chang JY; Liou JP
Eur J Med Chem; 2014 Apr; 77():306-14. PubMed ID: 24657567
[TBL] [Abstract][Full Text] [Related]
15. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
16. Comparative QSAR modelling of 2-phenylindole-3-carbaldehyde derivatives as potential antimitotic agents.
Halder AK; Adhikari N; Jha T
Bioorg Med Chem Lett; 2009 Mar; 19(6):1737-9. PubMed ID: 19217281
[TBL] [Abstract][Full Text] [Related]
17. SAR studies of 2-methoxyestradiol and development of its analogs as probes of anti-tumor mechanisms.
Ho A; Kim YE; Lee H; Cyrus K; Baek SH; Kim KB
Bioorg Med Chem Lett; 2006 Jul; 16(13):3383-7. PubMed ID: 16650989
[TBL] [Abstract][Full Text] [Related]
18. 7,11-epi-thyrsiferol: completion of its synthesis, evaluation of its antimitotic properties, and the further development of an SAR model.
Nishiguchi GA; Graham J; Bouraoui A; Jacobs RS; Little RD
J Org Chem; 2006 Aug; 71(16):5936-41. PubMed ID: 16872175
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative evaluation of certain pyrido[3,2-g]quinoline derivatives.
Li SY; Chen YL; Wang C; Tzeng CC
Bioorg Med Chem; 2006 Nov; 14(22):7370-6. PubMed ID: 16887354
[TBL] [Abstract][Full Text] [Related]
20. Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationships.
Song DQ; Wang Y; Wu LZ; Yang P; Wang YM; Gao LM; Li Y; Qu JR; Wang YH; Li YH; Du NN; Han YX; Zhang ZP; Jiang JD
J Med Chem; 2008 Jun; 51(11):3094-103. PubMed ID: 18457382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
